Insider Trading June 30, 2026 04:48 PM

Vicor Chairman and CEO Patrizio Vinciarelli Executes $3.2 Million Stock Sale Under Pre-Arranged Plan

Executive divestment occurs as the power systems manufacturer reports strong Q1 earnings and raises Q2 guidance, though valuation metrics suggest caution for investors.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
VICR

Vicor Corp (NASDAQ:VICR) Chairman and Chief Executive Officer Patrizio Vinciarelli has sold approximately $3.2 million worth of company stock. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan established in February 2026. The sales coincide with a period of significant stock price appreciation and strong recent financial performance for the company.

Vicor Chairman and CEO Patrizio Vinciarelli Executes $3.2 Million Stock Sale Under Pre-Arranged Plan
VICR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Vicor Corp Chairman and CEO Patrizio Vinciarelli sold $3.2 million in stock under a Rule 10b5-1 plan established in February 2026.
  • The company reported strong Q1 2026 financial results, with EPS of $0.44 beating expectations and revenue of $112.97 million exceeding forecasts by 3.59%.
  • Needham raised its price target to $400 with a Buy rating, citing a revised long-term revenue target of $2.5 billion and new patent license royalties.

Patrizio Vinciarelli, who serves as both Chairman and Chief Executive Officer of Vicor Corp (NASDAQ:VICR), has completed a series of stock sales totaling $3,214,708. These transactions were finalized on June 29, 2026, and were conducted in accordance with a pre-arranged Rule 10b5-1 trading plan. The plan itself was established by Mr. Vinciarelli on February 26, 2026, providing the structured framework for these divestments.

The timing of these sales is notable given the recent performance of Vicor Corp's shares. The stock has traded near its 52-week high of $370, marking a substantial 709% return over the past year. Despite this upward trajectory, analysis from InvestingPro indicates that the stock may currently be overvalued relative to its Fair Value. This assessment places Vicor Corp among the most overvalued stocks tracked by the platform, suggesting a potential divergence between market price and intrinsic valuation metrics.

The $3.2 million sale was not a single lump-sum transaction but rather a series of individual trades executed at varying price points. One block of 2,560 shares was sold at a weighted average price of $365.5195, with individual transaction prices ranging from $364.9800 to $365.9400. A second block consisting of 2,700 shares was disposed of at a weighted average price of $366.7095, with prices falling between $366.0100 and $366.9400. Further transactions included the sale of 1,200 shares at a weighted average price of $367.6209, with prices ranging from $367.0700 to $368.0100. Another 2,100 shares were sold at a weighted average price of $368.5005, with prices between $368.0900 and $368.9900. The final reported transaction involved the sale of 200 shares at a weighted average price of $369.3350, with prices ranging from $369.1100 to $369.5600.

Following these divestments, Mr. Vinciarelli continues to maintain a significant stake in the company. He directly holds 8,408,090 shares of Vicor Corp common stock. As a director and a ten percent owner of the company, his holdings remain substantial despite the recent sales.

The executive's stock activity comes amidst a period of strong financial performance for Vicor Corp. The company reported first-quarter 2026 earnings per share of $0.44, which surpassed analyst expectations of $0.37. Revenue for the quarter reached $112.97 million, exceeding forecasts by 3.59%. In response to this performance, Vicor has increased its second-quarter revenue guidance from $126 million to $142 million. The company attributes this upward revision to enhanced product revenues and royalties generated from a new patent license agreement. This agreement involves an original equipment manufacturer securing a comprehensive license for Vicor's patented power system technology.

Market analysts have responded positively to these developments. Needham has raised its price target for Vicor to $400, maintaining a Buy rating. The firm highlighted the company's revised long-term revenue target of $2.5 billion as a key factor in its optimistic outlook. Additionally, Vicor's shareholders recently elected eleven directors at the annual meeting and approved executive compensation, signaling continued confidence in the company's governance and strategic direction.

Risks

  • InvestingPro analysis indicates the stock may be overvalued relative to its Fair Value, placing it among the most overvalued stocks tracked, which could signal a valuation correction risk in the power systems sector.
  • The executive's sales occur near the stock's 52-week high of $370, following a 709% annual return, which may indicate near-term volatility or profit-taking pressures in the technology and semiconductor markets.

More from Insider Trading

Remitly Director Joshua Hug Executes $764,400 Stock Sale Under Pre-Arranged Plan Jun 30, 2026 Teladoc Health President Kelly Bliss Executes $21,250 Stock Sale Under Pre-Arranged Plan Jun 30, 2026 Disc Medicine's Chief Legal Officer Executes $187,500 Stock Sale Under Pre-Arranged Plan Jun 30, 2026 Ionis Pharmaceuticals EVP Joseph Baroldi’s Spouse Executes Pre-Arranged Stock Sales and Acquisitions Jun 30, 2026 Ionis Pharmaceuticals Executive Offloads Shares Under Pre-Arranged Plan Jun 30, 2026